ref_name,rx_name,gene,position,amino_acid,section,date_added
FDA21,Bamlanivimab,S,484,D,BAM page 21,2021-03-20
FDA21,Bamlanivimab,S,484,K,BAM page 21,2021-03-20
FDA21,Bamlanivimab,S,484,Q,BAM page 21,2021-03-20
FDA21,Bamlanivimab,S,490,S,BAM page 21,2021-03-20
FDA21,Bamlanivimab,S,493,R,BAM page 21,2021-03-20
FDA21,Bamlanivimab,S,494,P,BAM page 21,2021-03-20
FDA21,Bamlanivimab,S,417,N,BAM + ETE page 26,2021-03-20
FDA21,Bamlanivimab,S,420,N,BAM + ETE page 26,2021-03-20
FDA21,Bamlanivimab,S,460,K,BAM + ETE page 26,2021-03-20
FDA21,Bamlanivimab,S,460,S,BAM + ETE page 26,2021-03-20
FDA21,Bamlanivimab,S,460,T,BAM + ETE page 26,2021-03-20
FDA21,Casirivimab,S,417,E,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,417,N,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,417,R,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,453,F,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,455,F,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,484,K,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,486,V,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,493,K,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,444,N,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,444,Q,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,444,T,CAS + IMD page 23,2021-03-20
FDA21,Casirivimab,S,445,A,CAS + IMD page 23,2021-03-20
FDA21,Sotrovimab,S,340,A,SOT page 22,2021-06-07
FDA21,Sotrovimab,S,340,K,SOT page 23,2021-06-07
FDA21,Sotrovimab,S,344,V,SOT page 23,2021-06-07
FDA21,Sotrovimab,S,356,R,SOT page 23,2021-06-07
FDA21,Sotrovimab,S,359,G,SOT page 23,2021-06-07
